DIAGNOS (CVE:ADK) Director Robert Dunn Acquires 105,000 Shares of Stock

DIAGNOS Inc. (CVE:ADK) Director Robert Dunn purchased 105,000 shares of the company’s stock in a transaction dated Friday, August 28th. The stock was acquired at an average price of C$0.48 per share, with a total value of C$50,400.00. Following the completion of the transaction, the director owned 2,679,920 shares of the company’s stock, valued at C$1,286,361.60. This represents a 4.08% increase in their position.

Robert Dunn also recently made the following trade(s):

• On Wednesday, July 29th, Robert Dunn purchased 200,000 shares of DIAGNOS stock. The stock was bought at an average price of C$0.30 per share, with a total value of C$60,000.00.

DIAGNOS Trading Up 2.0%

Shares of CVE:ADK opened at C$0.50 on Friday. The business’s 50 day simple moving average is C$0.30 and its 200 day simple moving average is C$0.27. DIAGNOS Inc. has a 1 year low of C$0.17 and a 1 year high of C$0.52. The company has a debt-to-equity ratio of 204.05, a current ratio of 1.49 and a quick ratio of 0.68. The company has a market capitalization of C$60.21 million, a P/E ratio of -12.50 and a beta of -0.14.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.